Improving the Early Detection of Cardiometabolic Disease Risk
NCT ID: NCT05885672
Last Updated: 2024-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
200 participants
OBSERVATIONAL
2023-09-11
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question\[s\] it aims to answer are:
* Can a smartphone-based imaging system accurately predict a continuous metabolic syndrome severity score, in addition to other markers of cardiometabolic disease, in young adults?
* What is the relationship between autonomic dysfunction and metabolic syndrome severity in a cohort of young adults?
* What is the relationship between peripheral vascular dysfunction and metabolic syndrome severity in a cohort of young adults?
* What are the associations between metabolic syndrome severity and gait and functional ability in young adults using novel markerless motion capture technology?
* What are the attitudes and barriers towards lifestyle interventions targeted to reduce metabolic syndrome severity?
* What are the treatment-seeking and willingness to engage behaviors toward a webpage focused on lifestyle interventions to reduce metabolic syndrome severity?
Participants will be asked to undergo several assessments across four separate days which are design designed to determine the associations between cardiometabolic health markers and components of:
* body composition
* cardiovascular function
* functional ability
* attitudes and behaviors towards health-related interventions
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Metabolic Indicator Study
NCT03588117
Integrating Lifestyle Therapy for Diabetes Prevention Into Primary Care
NCT00853801
Fertility and Cardiovascular Risk in Men With Metabolic Syndrome
NCT03977064
The Reversal Intervention for Metabolic Syndrome Study
NCT01043770
Effect of Dietary Habits on Metabolic Health
NCT02298790
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Young Adults
Adults between the ages of 18 and 39 years
Online psychoeducational lifestyle intervention
A webpage-baed intervention focused on lifestyle interventions that aim to reduce metabolic syndrome severity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Online psychoeducational lifestyle intervention
A webpage-baed intervention focused on lifestyle interventions that aim to reduce metabolic syndrome severity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant
* Breastfeeding or lactating
* Missing any limbs or part of a limb
* Having a substantial amount of metal implants (metal plates or complete joint replacements)
* Having a pacemaker or any other electrical implant
* Type I diabetes
* Gestational diabetes
* Taking insulin
* Diagnosed heart failure, cardiomyopathy (dilated or hypertrophic), valvular disease
* Any history of severe traumatic brain injury or mild traumatic brain injury within the last two years
* Kidney disease
* Liver disease
* Thyroid disease
* Any diagnosed neurological or neurodegenerative diseases
* Having received ionizing radiation from a medical procedure within the last 30 days
* Being on a medically prescribed diet
* Having donated blood or plasma in the last 20 days prior to blood collection procedures
* Taking any supplements/medications that may interfere with the results of the study
* Any injury or physical impairment that would prevent performing any functional measures for this study
18 Years
39 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Mississippi Medical Center
OTHER
University of Southern Mississippi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Austin J Graybeal, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Southern Mississippi
Jon Stavres, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Southern Mississippi
Tanner Thorsen, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Southern Mississippi
Megan Renna, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Southern Mississippi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Southern Mississippi - School of Kinesiology and Nutrition
Hattiesburg, Mississippi, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Graybeal AJ, Compton AT, Swafford SH, Brandner CF, Thorsen T, Renna ME, Stavres J. Measurements of Abdominal Obesity are Associated with Metabolic Syndrome Severity Independent of Hypertensive Phenotype in White but not Black Young Adults. J Racial Ethn Health Disparities. 2025 Aug;12(4):2299-2311. doi: 10.1007/s40615-024-02051-8. Epub 2024 Jun 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-0446
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.